Categories: News

Aveanna Announces Third Quarter 2021 Earnings Release Date and Conference Call

ATLANTA, Oct. 27, 2021 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) today announced that the company will release its third quarter results after the market close on Monday, November 15, 2021, to be followed by a conference call on Tuesday, November 16, 2021 at 10:00 a.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13724184. The replay will be available until November 23, 2021.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for one week following the call.

About Aveanna Healthcare

Aveanna Healthcare is headquartered in Atlanta, Georgia and has operations in 30 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.

Investor Contact

Dave Afshar
Chief Financial Officer
ir@aveanna.com

 

Staff

Recent Posts

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists…

3 hours ago

BoomRx Debuts Single Portal for Prescription Sourcing and Fulfillment

New Technology Platform Reduces Administrative Burden for Healthcare Providers NationwideTAMPA, Fla., Dec. 12, 2025 /PRNewswire/…

3 hours ago

CluePoints Scoops Prestigious 2025 Scrip Award

RBQM and AI leader wins the 'Best Contract Research Organization – Specialist Providers' categoryKING OF…

3 hours ago

Global Attention: POGMENT Biomimetic Collagen “Stable Triple-Helix Breakthrough” –Unconventional and Astonishing

— LivingPhoenix Forum's 12 Conference Presentation Ignite International and Domestic Academia, Hailed by Academicians as…

3 hours ago

Acclinate Named Bronze Winner for Digital Health Innovation at the 5th Annual Anthem Awards

BIRMINGHAM, Ala., Dec. 12, 2025 /PRNewswire/ -- Acclinate announced today that its community platform, NOWINCLUDED,…

3 hours ago

Cadrenal’s Quiet Expansion Play Is Starting to Get Loud

PONTE VEDRA, FL / ACCESS Newswire / December 12, 2025 / Cadrenal Therapeutics (NASDAQ:CVKD) entered…

3 hours ago